Search by Ticker
Alexion Pharmaceuticals (NASDAQ:ALXN)
The following stock analysis is based on 7.2 years of data (i.e. since May 07, 2013). All the stock history has been downloaded.
Alexion Pharmaceuticals trades on the NasdaqGS exchange in USD dollars.
It is in the sector.
It is currently trading at $105.22 ($104.85 the previous day).
The next reporting date is in 78 days (2020 10 22).
CNN estimates profits for the upcoming quarter will be $2.48 per share ($1.4B). The current Canada / US exchange rate is 1.326.
Over the past 12 months, $39465065 worth of shares have been purchased and $785981 worth of shares have been sold by insiders.
The year over year average increase is -12.0% per year assuming steady exponential growth. The actual 5 year average is -9.92. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||104.46794761905||-15.2||- Below Average|
|2 year||123.16269076305||-0.1||+ Above Average|
|3 year||123.25731092437||-0.8||+ Above Average|
|4 year||124.24167346939||-19.1||- Below Average|
|5 year||153.48041825095||-14.4||- Below Average|
The worst drop it has had in recent years is -61.3%. It has a shape to the stock curve, which means
Alexion Pharmaceuticals (ALXN) Q2 2020 Earnings Call TranscriptFri, 31 Jul 2020 11:31:37 Ladies and gentlemen, thank you for standing by, and welcome to Alexion Pharmaceuticals second-quarter 2020 results conference call. Thank you for joining us on today's call to discuss Alexion's performance for the second quarter of 2020. Today's call will be led by ...... Read Full Article
Got $200? Here Are 3 Smart Stocks to Invest in NowFri, 31 Jul 2020 09:51:00 One high-octane company investors should be particularly excited about over the long run is social-media platform Pinterest (NYSE: PINS). You'd think that getting things right on social media would be pretty easy, but it's a lot tougher than you'd think ...... Read Full Article
10 Biggest Biotechnology CompaniesThu, 30 Jul 2020 23:32:40 With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.... Read Full Article
Whatand's Behind Alexion Pharmaceuticalsand' Strong Q2 ResultsThu, 30 Jul 2020 16:00:00 Alexion Pharmaceuticals (NASDAQ: ALXN) stock has been on a big roll over the last few months. Alexion announced a net loss in Q2 of $1.1 billion, or $4.84 per share, based on generally accepted accounting principles (GAAP). Alexion recorded adjusted non-GAAP earnings ...... Read Full Article
Alexion (ALXN) Beats on Q2 Earnings andand Sales, Ups and'20 GuidanceThu, 30 Jul 2020 15:14:03 Alexion (ALXN) beats on earnings and sales in the second quarter of 2020.... Read Full Article
Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue EstimatesThu, 30 Jul 2020 14:55:02 Alexion (ALXN) delivered earnings and revenue surprises of 21.96% and 14.12%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article
Recap: Alexion Pharmaceuticals Q2 EarningsThu, 30 Jul 2020 11:50:05 Shares of Alexion Pharmaceuticals (NASDAQ:ALXN) rose 1.3% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share increased 17.80% year over year to $3.11, which beat the estimate of $2.59.Revenue of $1,444,600,000 rose by 20.08% year over year, which beat ...... Read Full Article
Alexion Reports Second Quarter 2020 ResultsThu, 30 Jul 2020 10:30:00 Alexion Reports Second Quarter 2020 Results... Read Full Article
Why Earnings Season Could Be Great for Alexion (ALXN)Wed, 29 Jul 2020 12:27:12 Alexion (ALXN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.... Read Full Article
Top Health Care Stocks for August 2020Tue, 28 Jul 2020 19:18:23 Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as ...... Read Full Article
4 More Biotechs Break From IPO Starting GateMon, 27 Jul 2020 22:07:29 Inozyme Pharma is biggest gainer in first week as a public company Continue reading...... Read Full Article
Strength in Alexion Pharmaceuticals May Be TemporaryMon, 27 Jul 2020 19:25:00 Alexion Pharmaceuticals is up sharply Monday but this strength only looks temporary. Letand's check out the charts and indicators. In the updated daily bar chart of ALXN, below, we can see that the shares briefly broke below the rising 200-day ...... Read Full Article
Alexion (ALXN) to Report Q2 Earnings: Whatand's in the Cards?Fri, 24 Jul 2020 17:13:05 Alexion (ALXN) will provide financial and corporate updates when it releases second-quarter 2020 results on Jul 30.... Read Full Article
Earnings Preview: Alexion Pharmaceuticals (ALXN) Q2 Earnings Expected to DeclineThu, 23 Jul 2020 16:32:04 Alexion (ALXN) doesnand't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article
Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)Sun, 19 Jul 2020 15:54:53 I find it very interesting that Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) after going public in 2001, did not generate their first profit until December 2008. As we all know, this was in the throes of what is now known as the Great ...... Read Full Article
Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020Thu, 16 Jul 2020 10:30:00 Alexion to Report Second Quarter 2020 Results on Thursday, July 30, 2020... Read Full Article
Alexion Pharmaceuticals (ALXN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Wed, 15 Jul 2020 16:31:04 Alexion (ALXN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article
Drugmaker Alexion Needs to Ditch Its Acquisitions Strategy, Analyst WritesTue, 14 Jul 2020 17:11:00 SVB Leerink analyst Geoffrey Porges argues that the drugmaker’s acquisitions aren’t working, and that the whole capital allocation strategy needs a revamp.... Read Full Article
Alexion Pharmaceuticals, Inc.and's (NASDAQ:ALXN) Stock Been Rising: Are Strong Financials Guiding The Market?Mon, 13 Jul 2020 15:25:10 Alexion Pharmaceuticalsand' (NASDAQ:ALXN) stock is up by 9.5% over the past three months. Since the market usually pay...... Read Full Article
Were Hedge Funds Right About Piling Into Alexion Pharmaceuticals, Inc. (ALXN)?Wed, 08 Jul 2020 17:21:52 We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional ...... Read Full Article